Mortality and causes of death in systemic lupus erythematosus

被引：201

作者：

Trager, J

Ward, MM

机构：

[1] Dept Vet Affairs Palo Alto Hlth Care Syst, Med Serv, Palo Alto, CA 94304 USA

[2] Stanford Univ, Dept Med, Div Rheumatol & Immunol, Sch Med, Stanford, CA 94305 USA

来源：

CURRENT OPINION IN RHEUMATOLOGY | 2001年 / 13卷 / 05期

关键词：

D O I：

10.1097/00002281-200109000-00002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cohort studies of survival in systemic lupus erythematosus (SLE) often have been limited by methodologic problems. In studies of inception cohorts of patients followed since 1980, survival at 5 years has exceeded 90%. These estimates are generally higher than survival estimates from earlier studies, suggesting that short-term survival in SLE has improved. There is less evidence to support major improvements over time in survival after 10 years or more of SLE Infections, atherosclerotic disease, and active systemic lupus erythematosus or organ damage caused by SLE are the main causes of death in patients with SLE, but the proportion of early deaths caused by active SLE has decreased over time.

引用

页码：345 / 351

页数：7

共 78 条

[11]

Cameron JS, 1999, J AM SOC NEPHROL, V10, P413

[12] Morbidity and mortality in systemic lupus erythematosus during a 5-year period -: A multicenter prospective study of 1,000 patients [J].